AUPH vs LKFT: stock comparison and AI forecast
Aurinia Pharmaceuticals Inc. (AUPH) and Lakefront Biotherapeutics Nv (LKFT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AUPH Aurinia Pharmaceuticals Inc.
- Market Cap
- $2.17B
- P/E Ratio
- 7.8x
- Size
- mid-cap
- AI Forecast
LKFT Lakefront Biotherapeutics Nv
- Market Cap
- $2.21B
- P/E Ratio
- 5.0x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- AUPH and LKFT have similar market capitalizations ($2.17B and $2.21B).
- LKFT trades at 5.0 times trailing earnings, AUPH at 7.8 times.
- AUPH turns 97.7% of its revenue into net income, against 18.2% for LKFT.
- AUPH carries 0.26 times debt per unit of equity, against 0.05 times for LKFT.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AUPH | LKFT |
|---|---|---|
| Market Cap | $2.17B | $2.21B |
| P/E Ratio | 7.83x | 5.04x |
| P/B Ratio | 3.30x | – |
| EPS | $2.07 | $6.66 |
| Book Value/Share | $4.91 | – |
| Revenue/Share | $2.40 | $36.68 |
| FCF/Share | – | $-26.83 |
Profitability & Margins
| Metric | AUPH | LKFT |
|---|---|---|
| ROE | 47.8% | 12.0% |
| ROA | 38.1% | 11.4% |
| ROIC | 21.4% | -7.7% |
| Gross Margin | 90.6% | 96.3% |
| Operating Margin | 48.6% | -11.7% |
| Net Margin | 97.7% | 18.2% |
| EBT Margin | 51.9% | 4.1% |
| Tax Rate | -88.0% | -9.0% |
Financial Health
| Metric | AUPH | LKFT |
|---|---|---|
| Current Ratio | 6.12x | 20.15x |
| Quick Ratio | 5.67x | 20.00x |
| D/E Ratio | 0.26x | 0.05x |
| Financial Leverage | 1.26x | 1.05x |
| Working Capital | $492M | $3.44B |
Cash Flow
| Metric | AUPH | LKFT |
|---|---|---|
| Operating Cash Flow | $177M | -$1.68B |
| Free Cash Flow | – | -$1.77B |
| Capital Spending | – | -$87M |
| OCF Growth YoY | 47.5% | – |
| FCF/Sales | – | -73.2% |
| CapEx/Sales | – | 3.6% |
Operational Efficiency
| Metric | AUPH | LKFT |
|---|---|---|
| Asset Turnover | 0.39x | 0.63x |
| Receivables Turnover | – | 103.0x |
| Inventory Turnover | 0.7x | 3.5x |
| Fixed Assets Turnover | 185.2x | 29.6x |
| Days Sales Outstanding | – | 4 days |
| Days Inventory | 529 days | 105 days |
| Payables Period | 36 days | 488 days |
| Cash Conversion Cycle | – | -379 days |
Income Statement
| Metric | AUPH | LKFT |
|---|---|---|
| Total Revenue | $322M | $2.42B |
| Operating Income | $156M | -$282M |
| Net Income | $314M | $440M |
| R&D Expense | $48M | $1.76B |
| Cost of Goods Sold | $30M | $89M |
Dividend & Shareholder Information
| Metric | AUPH | LKFT |
|---|---|---|
| Shares Outstanding | 134M | 66M |
| Net Income Growth | 303.8% | – |
| EPS Growth | 1117.7% | – |
AUPH vs LKFT: stock comparison and AI forecast
Which is bigger, AUPH or LKFT?
AUPH and LKFT have similar market capitalizations ($2.17B and $2.21B).
Which is cheaper on earnings, AUPH or LKFT?
LKFT trades at 5.0 times trailing earnings, AUPH at 7.8 times.
Which one does Intratio's AI model rank higher, AUPH or LKFT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.